These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

960 related items for PubMed ID: 18264787

  • 1. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1).
    van Beijnum JR, Buurman WA, Griffioen AW.
    Angiogenesis; 2008; 11(1):91-9. PubMed ID: 18264787
    [Abstract] [Full Text] [Related]

  • 2. Dealing with death: HMGB1 as a novel target for cancer therapy.
    Lotze MT, DeMarco RA.
    Curr Opin Investig Drugs; 2003 Dec; 4(12):1405-9. PubMed ID: 14763124
    [Abstract] [Full Text] [Related]

  • 3. Monocytes promote natural killer cell interferon gamma production in response to the endogenous danger signal HMGB1.
    DeMarco RA, Fink MP, Lotze MT.
    Mol Immunol; 2005 Feb; 42(4):433-44. PubMed ID: 15607795
    [Abstract] [Full Text] [Related]

  • 4. Mini-review: The nuclear protein HMGB1 as a proinflammatory mediator.
    Erlandsson Harris H, Andersson U.
    Eur J Immunol; 2004 Jun; 34(6):1503-12. PubMed ID: 15162419
    [Abstract] [Full Text] [Related]

  • 5. High mobility group box 1 promotes small intestinal damage induced by nonsteroidal anti-inflammatory drugs through Toll-like receptor 4.
    Nadatani Y, Watanabe T, Tanigawa T, Machida H, Okazaki H, Yamagami H, Watanabe K, Tominaga K, Fujiwara Y, Arakawa T.
    Am J Pathol; 2012 Jul; 181(1):98-110. PubMed ID: 22634181
    [Abstract] [Full Text] [Related]

  • 6. The role of HMGB1/RAGE in inflammatory cardiomyopathy.
    Volz HC, Kaya Z, Katus HA, Andrassy M.
    Semin Thromb Hemost; 2010 Mar; 36(2):185-94. PubMed ID: 20414834
    [Abstract] [Full Text] [Related]

  • 7. Activation of Toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development.
    Zurolo E, Iyer A, Maroso M, Carbonell C, Anink JJ, Ravizza T, Fluiter K, Spliet WG, van Rijen PC, Vezzani A, Aronica E.
    Brain; 2011 Apr; 134(Pt 4):1015-32. PubMed ID: 21414994
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of tumor angiogenesis by HMGB1 A box peptide.
    Zhang CL, Shu MG, Qi HW, Li LW.
    Med Hypotheses; 2008 Apr; 70(2):343-5. PubMed ID: 17630223
    [Abstract] [Full Text] [Related]

  • 9. High-mobility group box-1 in ischemia-reperfusion injury of the heart.
    Andrassy M, Volz HC, Igwe JC, Funke B, Eichberger SN, Kaya Z, Buss S, Autschbach F, Pleger ST, Lukic IK, Bea F, Hardt SE, Humpert PM, Bianchi ME, Mairbäurl H, Nawroth PP, Remppis A, Katus HA, Bierhaus A.
    Circulation; 2008 Jun 24; 117(25):3216-26. PubMed ID: 18574060
    [Abstract] [Full Text] [Related]

  • 10. Extracellular high mobility group box-1 inhibits R5 and X4 HIV-1 strains replication in mononuclear phagocytes without induction of chemokines and cytokines.
    Cassetta L, Fortunato O, Adduce L, Rizzi C, Hering J, Rovere-Querini P, Bianchi ME, Alfano M, Poli G.
    AIDS; 2009 Mar 13; 23(5):567-77. PubMed ID: 19194273
    [Abstract] [Full Text] [Related]

  • 11. Lung level of HMBG1 is elevated in response to advanced glycation end product-enriched food in vivo.
    Bartling B, Fuchs C, Somoza V, Niemann B, Silber RE, Simm A.
    Mol Nutr Food Res; 2007 Apr 13; 51(4):479-87. PubMed ID: 17357979
    [Abstract] [Full Text] [Related]

  • 12. Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells.
    Dumitriu IE, Baruah P, Bianchi ME, Manfredi AA, Rovere-Querini P.
    Eur J Immunol; 2005 Jul 13; 35(7):2184-90. PubMed ID: 15915542
    [Abstract] [Full Text] [Related]

  • 13. Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1.
    van Beijnum JR, Nowak-Sliwinska P, van den Boezem E, Hautvast P, Buurman WA, Griffioen AW.
    Oncogene; 2013 Jan 17; 32(3):363-74. PubMed ID: 22391561
    [Abstract] [Full Text] [Related]

  • 14. RAGE and TLRs: relatives, friends or neighbours?
    Ibrahim ZA, Armour CL, Phipps S, Sukkar MB.
    Mol Immunol; 2013 Dec 17; 56(4):739-44. PubMed ID: 23954397
    [Abstract] [Full Text] [Related]

  • 15. Inhibitory effects of lycopene on HMGB1-mediated pro-inflammatory responses in both cellular and animal models.
    Lee W, Ku SK, Bae JW, Bae JS.
    Food Chem Toxicol; 2012 Jun 17; 50(6):1826-33. PubMed ID: 22429818
    [Abstract] [Full Text] [Related]

  • 16. High-mobility group box protein 1 and its signalling receptors in human preterm and term cervix.
    Dubicke A, Andersson P, Fransson E, Andersson E, Sioutas A, Malmström A, Sverremark-Ekström E, Ekman-Ordeberg G.
    J Reprod Immunol; 2010 Jan 17; 84(1):86-94. PubMed ID: 19962765
    [Abstract] [Full Text] [Related]

  • 17. HMGB1 as a DNA-binding cytokine.
    Andersson U, Erlandsson-Harris H, Yang H, Tracey KJ.
    J Leukoc Biol; 2002 Dec 17; 72(6):1084-91. PubMed ID: 12488489
    [Abstract] [Full Text] [Related]

  • 18. Neutralization of receptor for advanced glycation end-products and high mobility group box-1 attenuates septic diaphragm dysfunction in rats with peritonitis.
    Susa Y, Masuda Y, Imaizumi H, Namiki A.
    Crit Care Med; 2009 Sep 17; 37(9):2619-24. PubMed ID: 19623040
    [Abstract] [Full Text] [Related]

  • 19. High-mobility group box 1 protein is an inflammatory mediator in necrotizing enterocolitis: protective effect of the macrophage deactivator semapimod.
    Zamora R, Grishin A, Wong C, Boyle P, Wang J, Hackam D, Upperman JS, Tracey KJ, Ford HR.
    Am J Physiol Gastrointest Liver Physiol; 2005 Oct 17; 289(4):G643-52. PubMed ID: 15947118
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms of disease: a 'DAMP' view of inflammatory arthritis.
    Foell D, Wittkowski H, Roth J.
    Nat Clin Pract Rheumatol; 2007 Jul 17; 3(7):382-90. PubMed ID: 17599072
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.